Cite
Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery Platform
MLA
Ashok Narasimhan, et al. “Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery Platform.” Cancers, vol. 12, no. 12, Dec. 2020, p. 3787. EBSCOhost, https://doi.org/10.3390/cancers12123787.
APA
Ashok Narasimhan, Safi Shahda, Joshua K. Kays, Susan M. Perkins, Lijun Cheng, Katheryn N. H. Schloss, Daniel E. I. Schloss, Leonidas G. Koniaris, & Teresa A. Zimmers. (2020). Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery Platform. Cancers, 12(12), 3787. https://doi.org/10.3390/cancers12123787
Chicago
Ashok Narasimhan, Safi Shahda, Joshua K. Kays, Susan M. Perkins, Lijun Cheng, Katheryn N. H. Schloss, Daniel E. I. Schloss, Leonidas G. Koniaris, and Teresa A. Zimmers. 2020. “Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery Platform.” Cancers 12 (12): 3787. doi:10.3390/cancers12123787.